HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 45845,
"recordsTotal": 45845,
"next": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=status&start=18600",
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&ordering=status&start=18000",
"results": [
{
"registry_id": "NCT04542057",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04542057",
"title": "A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine Over 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease",
"has_exemption": false,
"start_date": "2020-09-22",
"completion_date": "2022-05-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Verona Pharma plc",
"sponsor_slug": "verona-pharma-plc",
"status": "reported-late",
"is_pact": false,
"days_late": 47
},
{
"registry_id": "NCT04365400",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04365400",
"title": "A Randomised, Double-Blind, Placebo-Controlled, Dose Finding Phase IIb Study to Assess the Efficacy and Safety of Orally Administered Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes",
"has_exemption": false,
"start_date": "2020-10-13",
"completion_date": "2022-05-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Afimmune",
"sponsor_slug": "afimmune",
"status": "reported-late",
"is_pact": false,
"days_late": 2
},
{
"registry_id": "NCT04662086",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04662086",
"title": "COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19",
"has_exemption": false,
"start_date": "2021-04-23",
"completion_date": "2022-05-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04662060",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04662060",
"title": "COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19",
"has_exemption": false,
"start_date": "2021-04-23",
"completion_date": "2022-05-03",
"has_results": true,
"results_due": true,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02446626",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02446626",
"title": "Xenodiagnosis After Antibiotic Treatment for Lyme Disease - Phase II Study",
"has_exemption": true,
"start_date": "2015-07-24",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02633397",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02633397",
"title": "A Phase II Randomized, Double-Blind, Placebo-Controlled Multi-Center Study to Assess the Safety, Tolerability, and Efficacy of Riociguat in Patients With Sickle Cell Diseases",
"has_exemption": false,
"start_date": "2017-04-11",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Mark Gladwin",
"sponsor_slug": "mark-gladwin",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03577106",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03577106",
"title": "A Pilot fMRI Study of TMS in Late-Life Severe Worry",
"has_exemption": false,
"start_date": "2018-12-06",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Carmen Andreescu",
"sponsor_slug": "carmen-andreescu",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03557385",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03557385",
"title": "Adenosine Contrast CorrELations in Evaluating RevAscularizaTION",
"has_exemption": false,
"start_date": "2019-01-17",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03846427",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03846427",
"title": "A Phase 2, Open-label Study of Zanubrutinib (BGB-3111) in Patients With Relapsed or Refractory Marginal Zone Lymphoma",
"has_exemption": false,
"start_date": "2019-02-19",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "BeiGene",
"sponsor_slug": "beigene",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03960580",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03960580",
"title": "A 24-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 and 372 μg of OPN-375 Twice a Day (BID) in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps",
"has_exemption": false,
"start_date": "2019-06-06",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Optinose US Inc.",
"sponsor_slug": "optinose-us-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 188
},
{
"registry_id": "NCT04657666",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04657666",
"title": "A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients With Multiple Sclerosis",
"has_exemption": false,
"start_date": "2020-12-21",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Jazz Pharmaceuticals",
"sponsor_slug": "jazz-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04506463",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04506463",
"title": "A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Single-administration, Multiple-Dose Study to Demonstrate the Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis",
"has_exemption": true,
"start_date": "2020-12-22",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Sun Pharmaceutical Industries Limited",
"sponsor_slug": "sun-pharmaceutical-industries-limited",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05161806",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05161806",
"title": "An Open-label, Single-arm, Multicenter Study in Patients With Neovascular Age-related Macular Degeneration to Evaluate the Safety of SOK583A1 (40 mg/mL), a Proposed Aflibercept Biosimilar Product, Provided in a Prefilled Syringe",
"has_exemption": false,
"start_date": "2022-03-11",
"completion_date": "2022-05-04",
"has_results": true,
"results_due": true,
"sponsor_name": "Sandoz",
"sponsor_slug": "sandoz",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01063751",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01063751",
"title": "A Prospective, Post-market, Multi-center Study of the Tritanium® Acetabular Shell",
"has_exemption": true,
"start_date": "2011-07-31",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03428126",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03428126",
"title": "Phase II Study of Durvalumab (MEDI4736) (Anti-PD-L1) and Trametinib (MEKi) in MSS Metastatic Colon Cancer",
"has_exemption": false,
"start_date": "2018-03-21",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03436862",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03436862",
"title": "A Phase II Single Arm Study of Nivolumab as Maintenance Therapy After Autologous Stem Cell Transplantation in Patients With Hodgkin Lymphoma at Risk of Relapse or Progression",
"has_exemption": false,
"start_date": "2018-05-23",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03354273",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03354273",
"title": "A Phase 3, Open-Label, Multicentre Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease",
"has_exemption": false,
"start_date": "2018-06-05",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "GE Healthcare",
"sponsor_slug": "ge-healthcare",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03978741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03978741",
"title": "Randomized, Comparator-controlled, Single Blinded, Multi-center Study Evaluating the Efficacy and Safety of Yoni.Fit in Women With Stress Urinary Incontinence",
"has_exemption": true,
"start_date": "2020-01-03",
"completion_date": "2022-05-05",
"has_results": false,
"results_due": true,
"sponsor_name": "Watkins Conti Products. Inc.",
"sponsor_slug": "watkins-conti-products-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 71
},
{
"registry_id": "NCT04281108",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04281108",
"title": "Fluticasone Propionate Oral Dispersible Tablet Formulation in Eosinophilic Esophagitis: A Two-Part, Randomized, Double-blind, Placebo-Controlled Study of APT-1011 With an Open-label Extension, in Adult Subjects With Eosinophilic Esophagitis",
"has_exemption": true,
"start_date": "2020-01-30",
"completion_date": "2022-05-05",
"has_results": false,
"results_due": true,
"sponsor_name": "Ellodi Pharmaceuticals, LP",
"sponsor_slug": "ellodi-pharmaceuticals-lp",
"status": "overdue",
"is_pact": false,
"days_late": 107
},
{
"registry_id": "NCT03939715",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03939715",
"title": "Anterior And Multi-Compartment Vaginal Prolapse Repair Augmented With Decellularized Human Dermal Allograft: A Prospactive, Randomized Controlled, Post Market Study",
"has_exemption": false,
"start_date": "2020-04-05",
"completion_date": "2022-05-05",
"has_results": false,
"results_due": true,
"sponsor_name": "Colorado Pelvic Floor Consultants",
"sponsor_slug": "colorado-pelvic-floor-consultants",
"status": "overdue",
"is_pact": false,
"days_late": 838
},
{
"registry_id": "NCT04575597",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04575597",
"title": "A Phase 2/3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MK-4482 in Non-Hospitalized Adults With COVID-19.",
"has_exemption": false,
"start_date": "2020-10-19",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04696055",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04696055",
"title": "An Open-Label Study of Regorafenib in Combination With Pembrolizumab in Patients With Advanced or Metastatic Hepatocellular Carcinoma (HCC) After PD1/PD-L1 Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2021-02-03",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04832425",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04832425",
"title": "A Phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2021-03-30",
"completion_date": "2022-05-05",
"has_results": false,
"results_due": true,
"sponsor_name": "Praxis Precision Medicines",
"sponsor_slug": "praxis-precision-medicines",
"status": "overdue",
"is_pact": false,
"days_late": 838
},
{
"registry_id": "NCT04731675",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04731675",
"title": "An Adaptive, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee",
"has_exemption": false,
"start_date": "2021-05-25",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "AmMax Bio, Inc.",
"sponsor_slug": "ammax-bio-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04888507",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04888507",
"title": "A Single Arm, Open-Label Study to Assess the Safety, Efficacy, and Pharmacodynamic Effects of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch From Eculizumab Therapy",
"has_exemption": true,
"start_date": "2021-07-08",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05065983",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05065983",
"title": "A Phase 2 Open-Label Study to Assess the Safety and Immunogenicity of PXVX0317 (Chikungunya Virus Virus-Like Particle Vaccine [CHIKV VLP], Aluminum Hydroxide Adjuvanted)",
"has_exemption": false,
"start_date": "2021-10-11",
"completion_date": "2022-05-05",
"has_results": true,
"results_due": true,
"sponsor_name": "Bavarian Nordic",
"sponsor_slug": "bavarian-nordic",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02849171",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02849171",
"title": "Pilot Study of 11C-Choline (11C-CH) PET in Assessing Post-treatment True Tumor Progression From Pseudo-progression in High-grade Gliomas",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2022-05-06",
"has_results": true,
"results_due": true,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03395314",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03395314",
"title": "A Randomized Active Placebo Controlled Trial of Ketamine in Borderline Personality Disorder",
"has_exemption": false,
"start_date": "2018-02-15",
"completion_date": "2022-05-06",
"has_results": true,
"results_due": true,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03575052",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03575052",
"title": "A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled, Safety Study of Pimavanserin Therapy in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease",
"has_exemption": false,
"start_date": "2018-05-21",
"completion_date": "2022-05-06",
"has_results": true,
"results_due": true,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 584
},
{
"registry_id": "NCT04743895",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04743895",
"title": "Randomized, Single Blinded Pilot Study of Stainless Steel Wire Cerclage Versus FiberTape® Cerclage",
"has_exemption": false,
"start_date": "2021-01-04",
"completion_date": "2022-05-06",
"has_results": false,
"results_due": true,
"sponsor_name": "Arthrex, Inc.",
"sponsor_slug": "arthrex-inc",
"status": "overdue",
"is_pact": false,
"days_late": 837
},
{
"registry_id": "NCT04817228",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04817228",
"title": "A Prospective Study Performed to Evaluate the Clinical Performance (Debridement), Safety and Pharmacology Effect of EscharEx (EX-02 Formulation) in Patients With Lower Leg Ulcers (VLU and DFU)",
"has_exemption": false,
"start_date": "2021-04-21",
"completion_date": "2022-05-06",
"has_results": false,
"results_due": true,
"sponsor_name": "MediWound Ltd",
"sponsor_slug": "mediwound-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 837
},
{
"registry_id": "NCT05884606",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05884606",
"title": "A Prospective Pilot Study of the Allurion Digital Behaviour Change Intervention",
"has_exemption": false,
"start_date": "2021-06-19",
"completion_date": "2022-05-06",
"has_results": false,
"results_due": true,
"sponsor_name": "Allurion Technologies",
"sponsor_slug": "allurion-technologies",
"status": "overdue",
"is_pact": false,
"days_late": 837
},
{
"registry_id": "NCT05109702",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05109702",
"title": "A Phase 3, Multicenter, Randomized, Double Masked and Placebo-Controlled Study Evaluating the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution 0.25% Compared to Placebo in Subjects With Dry Eye",
"has_exemption": true,
"start_date": "2021-11-18",
"completion_date": "2022-05-06",
"has_results": true,
"results_due": true,
"sponsor_name": "HanAll BioPharma Co., Ltd.",
"sponsor_slug": "hanall-biopharma-co-ltd",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05416268",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05416268",
"title": "An Objective Study to Compare the Diopsys NOVA and LKC RETeval Devices Using the Diopsys LID Electrodes and the LKC RETeval Self-Adhering Electrode Arrays",
"has_exemption": false,
"start_date": "2022-05-04",
"completion_date": "2022-05-06",
"has_results": false,
"results_due": true,
"sponsor_name": "Diopsys, Inc.",
"sponsor_slug": "diopsys-inc",
"status": "overdue",
"is_pact": false,
"days_late": 837
},
{
"registry_id": "NCT03362970",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03362970",
"title": "Improvements Through the Use of a Rapid Multiplex PCR Enteric Pathogen Detection Kit in Children With Hematochezia",
"has_exemption": false,
"start_date": "2018-06-15",
"completion_date": "2022-05-07",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Calgary",
"sponsor_slug": "university-of-calgary",
"status": "reported-late",
"is_pact": false,
"days_late": 381
},
{
"registry_id": "NCT04005053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04005053",
"title": "Identifying Biological Signatures of N-Acetylcysteine for Non-Suicidal Self-Injury in Adolescents and Young Adults",
"has_exemption": false,
"start_date": "2019-08-01",
"completion_date": "2022-05-08",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "reported-late",
"is_pact": false,
"days_late": 35
},
{
"registry_id": "NCT05105334",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05105334",
"title": "Combined Treatment With Nonablative Fractional Laser and Radiofrequency Microneedling for the Treatment of Acne Scars: A Prospective, Randomized, Split-Face Study",
"has_exemption": false,
"start_date": "2021-11-08",
"completion_date": "2022-05-08",
"has_results": false,
"results_due": true,
"sponsor_name": "Goldman, Butterwick, Fitzpatrick and Groff",
"sponsor_slug": "goldman-butterwick-fitzpatrick-and-groff",
"status": "overdue",
"is_pact": false,
"days_late": 835
},
{
"registry_id": "NCT01734928",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01734928",
"title": "A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2013-01-07",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02145351",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02145351",
"title": "Rate-Adaptive Atrial Pacing In Diastolic Heart Failure (RAPID-HF)",
"has_exemption": false,
"start_date": "2014-04-07",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02805504",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02805504",
"title": "Efficacy of the Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures",
"has_exemption": false,
"start_date": "2016-07-11",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02991456",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02991456",
"title": "Phase II Randomized Study to Evaluate Efficacy, Patient Satisfaction, and Compliance of the Oral Combination of Rolapitant (Varubi®) Plus Ondansetron vs. Ondansetron Monotherapy in Malignant Glioma Patients Receiving Radiotherapy (RT) and Concomitant Temozolomide",
"has_exemption": false,
"start_date": "2017-10-09",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03435640",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03435640",
"title": "A Phase 1/2, Open-label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-262 in Combination With Bempegaldesleukin (NKTR-214) With or Without Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumor Malignancies",
"has_exemption": false,
"start_date": "2018-03-15",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Nektar Therapeutics",
"sponsor_slug": "nektar-therapeutics",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03468985",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03468985",
"title": "A Randomized Phase II Trial of Nivolumab, Cabozantinib Plus Nivolumab, and Cabozantinib Plus Nivolumab Plus Ipilimumab in Patients With Previously Treated Non-Squamous NSCLC",
"has_exemption": false,
"start_date": "2018-05-07",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04055909",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04055909",
"title": "Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock. A Randomized, Double-blind, Placebo Controlled Dose Selection Study",
"has_exemption": false,
"start_date": "2019-11-13",
"completion_date": "2022-05-09",
"has_results": false,
"results_due": true,
"sponsor_name": "Inotrem",
"sponsor_slug": "inotrem",
"status": "reported-late",
"is_pact": false,
"days_late": 34
},
{
"registry_id": "NCT06442410",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06442410",
"title": "Comparison of Differential Target Multiplexed Spinal Cord Stimulation (DTM™ SCS) Therapy Combined With CMM to CMM Alone in the Treatment of Intractable Back Pain Subjects Without Previous History of Lumbar Surgery",
"has_exemption": false,
"start_date": "2020-07-24",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "MedtronicNeuro",
"sponsor_slug": "medtronicneuro",
"status": "reported-late",
"is_pact": false,
"days_late": 498
},
{
"registry_id": "NCT04822597",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04822597",
"title": "Optimizing Topical Pain Control for Breast Cancer Patients Undergoing Pre-operative Radiotracer Injection for Sentinel Lymph Node Mapping",
"has_exemption": false,
"start_date": "2021-04-23",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04784091",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04784091",
"title": "Randomized, Controlled, Multicenter, Double-Masked, Parallel, Phase 3 Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis",
"has_exemption": true,
"start_date": "2021-04-29",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Tarsus Pharmaceuticals, Inc.",
"sponsor_slug": "tarsus-pharmaceuticals-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04860505",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04860505",
"title": "Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens",
"has_exemption": false,
"start_date": "2021-05-20",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06770114",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT06770114",
"title": "A Clinical Study to Investigate a New Mouthwash Containing 0.075% CPC and 0.28% Zinc Lactate as Compared to a Fluoride Mouthwash Containing 0.044% NaF in Reducing Plaque and Helping Prevent Gum Problems on Dental Implants Over a 6-month Period of Product Use",
"has_exemption": false,
"start_date": "2021-10-18",
"completion_date": "2022-05-09",
"has_results": false,
"results_due": true,
"sponsor_name": "Colgate Palmolive",
"sponsor_slug": "colgate-palmolive",
"status": "overdue",
"is_pact": false,
"days_late": 834
},
{
"registry_id": "NCT05424549",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05424549",
"title": "A Randomized, Double-Masked, Vehicle-Controlled Crossover Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease",
"has_exemption": false,
"start_date": "2022-03-09",
"completion_date": "2022-05-09",
"has_results": true,
"results_due": true,
"sponsor_name": "Aldeyra Therapeutics, Inc.",
"sponsor_slug": "aldeyra-therapeutics-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 539
},
{
"registry_id": "NCT05504733",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05504733",
"title": "Evaluating the Functionality of a Novel Layperson Tourniquet: A Doppler Study",
"has_exemption": false,
"start_date": "2022-05-09",
"completion_date": "2022-05-09",
"has_results": false,
"results_due": true,
"sponsor_name": "Uniformed Services University of the Health Sciences",
"sponsor_slug": "uniformed-services-university-of-the-health-sciences",
"status": "overdue",
"is_pact": false,
"days_late": 834
},
{
"registry_id": "NCT01823198",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01823198",
"title": "NK Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies",
"has_exemption": false,
"start_date": "2013-06-11",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02553460",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02553460",
"title": "Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I",
"has_exemption": false,
"start_date": "2016-01-29",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02741323",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02741323",
"title": "Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients",
"has_exemption": false,
"start_date": "2017-01-01",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03434028",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03434028",
"title": "Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis",
"has_exemption": false,
"start_date": "2018-03-07",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03497975",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03497975",
"title": "A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study in Prurigo Nodularis (PN) With Nalbuphine ER Tablets for Pruritus Relief Through Itch Scratch Modulation (PRISM Study)",
"has_exemption": true,
"start_date": "2018-08-07",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "Trevi Therapeutics",
"sponsor_slug": "trevi-therapeutics",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04210310",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04210310",
"title": "A Pilot, Proof of Concept, Placebo-controlled, Parallel Study of the Effects of High Dose Intranasal Oxytocin for the Treatment of Tinnitus",
"has_exemption": false,
"start_date": "2020-01-15",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04447859",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04447859",
"title": "A Randomized Controlled Open Label Pilot Study Examining the Safety of a 16 Week Flexible Titration Regimen vs. Label-recommended 8-week Semaglutide Titration Regimen",
"has_exemption": false,
"start_date": "2020-02-23",
"completion_date": "2022-05-10",
"has_results": false,
"results_due": true,
"sponsor_name": "Tel-Aviv Sourasky Medical Center",
"sponsor_slug": "tel-aviv-sourasky-medical-center",
"status": "overdue",
"is_pact": false,
"days_late": 833
},
{
"registry_id": "NCT04301986",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04301986",
"title": "Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus",
"has_exemption": false,
"start_date": "2020-08-11",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04680975",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04680975",
"title": "A Phase 2, Open-label Multicenter Study to Evaluate the Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (dcSSc)",
"has_exemption": false,
"start_date": "2021-03-03",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "Kadmon, a Sanofi Company",
"sponsor_slug": "kadmon-a-sanofi-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04778059",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04778059",
"title": "Phase 2 Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravenous USB002 to Treat Patients With Respiratory Distress Due to COVID-19 Infection",
"has_exemption": false,
"start_date": "2021-07-27",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "US Biotest, Inc.",
"sponsor_slug": "us-biotest-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 124
},
{
"registry_id": "NCT04767698",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04767698",
"title": "Addition of Belimumab to B-cell Depletion to Produce Prolonged Remission of Relapsing-remitting Multiple Sclerosis Disease Activity",
"has_exemption": false,
"start_date": "2021-10-01",
"completion_date": "2022-05-10",
"has_results": true,
"results_due": true,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05320042",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05320042",
"title": "1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Ultra for Astigmatism Contact Lenses",
"has_exemption": false,
"start_date": "2022-02-14",
"completion_date": "2022-05-10",
"has_results": false,
"results_due": true,
"sponsor_name": "Bausch & Lomb Incorporated",
"sponsor_slug": "bausch-lomb-incorporated",
"status": "reported-late",
"is_pact": false,
"days_late": 113
},
{
"registry_id": "NCT02301611",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02301611",
"title": "A Prospective, Randomized, Blinded, Placebo-controlled, Phase IIb Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine vs Unloaded YCWP + DC and Embedded Phase I/IIa Trial With Tumor Lysate Particle Only (TLPO) Vaccine in Stage III and Stage IV (Resected) Melanoma to Prevent Recurrence.",
"has_exemption": false,
"start_date": "2015-01-31",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Elios Therapeutics, LLC",
"sponsor_slug": "elios-therapeutics-llc",
"status": "reported-late",
"is_pact": true,
"days_late": 536
},
{
"registry_id": "NCT02935634",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02935634",
"title": "A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants With Advanced Gastric Cancer (FRACTION-Gastric Cancer)",
"has_exemption": false,
"start_date": "2016-11-29",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03373604",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03373604",
"title": "Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240",
"has_exemption": false,
"start_date": "2017-12-11",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Patrick Lao",
"sponsor_slug": "patrick-lao",
"status": "reported-late",
"is_pact": false,
"days_late": 686
},
{
"registry_id": "NCT03502746",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03502746",
"title": "Phase II Study of Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma:Hoosier Cancer Research Network LUN15-299",
"has_exemption": false,
"start_date": "2018-06-26",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Arkadiusz Z. Dudek, MD",
"sponsor_slug": "arkadiusz-z-dudek-md",
"status": "reported-late",
"is_pact": false,
"days_late": 113
},
{
"registry_id": "NCT03637764",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03637764",
"title": "A Phase 1/2 Open-label, Multi-center, Safety, Preliminary Efficacy and Pharmacokinetic (PK) Study of Isatuximab (SAR650984) in Combination With Atezolizumab or Isatuximab Alone in Patients With Advanced Malignancies",
"has_exemption": false,
"start_date": "2018-08-06",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03497689",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03497689",
"title": "EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension",
"has_exemption": false,
"start_date": "2019-01-31",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "United Therapeutics",
"sponsor_slug": "united-therapeutics",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04101331",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04101331",
"title": "A Phase II Open-label Multicenter Study to Assess the Efficacy and Safety of AFM13 in Patients With Relapsed or Refractory CD30-positive Peripheral T-cell Lymphoma or Transformed Mycosis Fungoides (REDIRECT)",
"has_exemption": false,
"start_date": "2019-11-13",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Affimed GmbH",
"sponsor_slug": "affimed-gmbh",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03945175",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03945175",
"title": "Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening",
"has_exemption": true,
"start_date": "2020-07-15",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04590963",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04590963",
"title": "A Phase 3 Randomized, Double-blind, Multicenter, Global Study of Monalizumab or Placebo in Combination With Cetuximab in Participants With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With an Immune Checkpoint Inhibitor",
"has_exemption": true,
"start_date": "2020-10-02",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04640532",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04640532",
"title": "An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 in Combination With TL-895 for the Treatment of Relapsed or Refractory Myelofibrosis and KRT-232 for the Treatment of JAK Inhibitor Intolerant Myelofibrosis.",
"has_exemption": false,
"start_date": "2020-11-17",
"completion_date": "2022-05-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Kartos Therapeutics, Inc.",
"sponsor_slug": "kartos-therapeutics-inc",
"status": "overdue",
"is_pact": false,
"days_late": 832
},
{
"registry_id": "NCT04746911",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04746911",
"title": "An Open Label, 4-Week, Phase 2, Maximal Usage Pharmacokinetics and Safety Study of ARQ-151 Cream 0.3% Administered QD in Pediatric Subjects (Ages 2 to 5 Years Old) With Plaque Psoriasis",
"has_exemption": true,
"start_date": "2021-03-01",
"completion_date": "2022-05-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Arcutis Biotherapeutics, Inc.",
"sponsor_slug": "arcutis-biotherapeutics-inc",
"status": "overdue",
"is_pact": false,
"days_late": 101
},
{
"registry_id": "NCT04490018",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04490018",
"title": "Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix®, and When Administered Alone or Concomitantly With 9vHPV and Tdap-IPV Vaccines in Healthy Adolescents",
"has_exemption": false,
"start_date": "2021-03-16",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04864249",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04864249",
"title": "The Impact of a Neonatal Sleep Intervention on Postpartum Blood Pressure in Women With Hypertensive Disorders of Pregnancy",
"has_exemption": false,
"start_date": "2021-07-09",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Alisse Hauspurg",
"sponsor_slug": "alisse-hauspurg",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04987671",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04987671",
"title": "A Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS",
"has_exemption": false,
"start_date": "2021-08-05",
"completion_date": "2022-05-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Amylyx Pharmaceuticals Inc.",
"sponsor_slug": "amylyx-pharmaceuticals-inc",
"status": "overdue",
"is_pact": false,
"days_late": 832
},
{
"registry_id": "NCT05022329",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05022329",
"title": "A Multi-Centre 12 Month Parallel-Group Randomized Control Trial of BNT162b2 Versus mRNA( Messenger Ribonucleic Acid) -1273 COVID-19 Vaccine Boosters in Chronic Kidney Disease and Dialysis Patients With Poor Humoral Response Following COVID-19 ( Corona Virus Disease of 2019)Vaccination",
"has_exemption": false,
"start_date": "2021-09-30",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "Sunnybrook Health Sciences Centre",
"sponsor_slug": "sunnybrook-health-sciences-centre",
"status": "reported-late",
"is_pact": false,
"days_late": 218
},
{
"registry_id": "NCT05190354",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05190354",
"title": "Post Market Clinical Protocol - Xtremity Polymer Prosthetic Socket System",
"has_exemption": false,
"start_date": "2021-11-16",
"completion_date": "2022-05-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Medical Creations, Inc.",
"sponsor_slug": "medical-creations-inc",
"status": "overdue",
"is_pact": false,
"days_late": 832
},
{
"registry_id": "NCT05106335",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05106335",
"title": "A Randomized, Open-Label, Controlled, Multi-Center Phase III Clinical Study of Camrelizumab Combined With Famitinib Malate Versus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer Who Progressed on Prior Immune Checkpoint Inhibitor Treatment and Platinum-Based Chemotherapy",
"has_exemption": false,
"start_date": "2022-01-06",
"completion_date": "2022-05-11",
"has_results": false,
"results_due": true,
"sponsor_name": "Jiangsu HengRui Medicine Co., Ltd.",
"sponsor_slug": "jiangsu-hengrui-medicine-co-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 832
},
{
"registry_id": "NCT04566133",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04566133",
"title": "Phase II Study of Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).",
"has_exemption": false,
"start_date": "2022-02-15",
"completion_date": "2022-05-11",
"has_results": true,
"results_due": true,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "reported-late",
"is_pact": false,
"days_late": 1
},
{
"registry_id": "NCT00481091",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT00481091",
"title": "A Phase 1/2a Study Evaluating the Safety, Pharmacokinetics, and Efficacy of ABT-263 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia",
"has_exemption": false,
"start_date": "2007-07-25",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02072148",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02072148",
"title": "The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA)",
"has_exemption": false,
"start_date": "2014-03-31",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "reported-late",
"is_pact": true,
"days_late": 304
},
{
"registry_id": "NCT02478320",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02478320",
"title": "A Proof-of-Concept Study for Ilorasertib (ABT-348) Activity in Patients With CDKN2A-Deficient Advanced Solid Cancers: a Phase II Basket Trial",
"has_exemption": false,
"start_date": "2016-08-05",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02841995",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02841995",
"title": "A Phase 2a, Dose-Escalation, Open-Label Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease",
"has_exemption": false,
"start_date": "2016-09-15",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Kadmon, a Sanofi Company",
"sponsor_slug": "kadmon-a-sanofi-company",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03547518",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03547518",
"title": "Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation",
"has_exemption": false,
"start_date": "2018-03-13",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "William Beaumont Hospitals",
"sponsor_slug": "william-beaumont-hospitals",
"status": "reported-late",
"is_pact": false,
"days_late": 28
},
{
"registry_id": "NCT03182907",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03182907",
"title": "A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. Difficile Toxin B) in Children Aged 1 to <18 Years Receiving Antibacterial Drug Treatment for C. Difficile Infection (MODIFY III)",
"has_exemption": false,
"start_date": "2018-03-27",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03456115",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03456115",
"title": "Assessing Mechanical Nasal Obstruction, a Potential New Treatment Option.",
"has_exemption": false,
"start_date": "2018-10-01",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03994822",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03994822",
"title": "pRESET for Occlusive Stroke Treatment",
"has_exemption": false,
"start_date": "2019-10-04",
"completion_date": "2022-05-12",
"has_results": false,
"results_due": true,
"sponsor_name": "phenox Inc.",
"sponsor_slug": "phenox-inc",
"status": "overdue",
"is_pact": false,
"days_late": 831
},
{
"registry_id": "NCT03882177",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03882177",
"title": "StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis",
"has_exemption": false,
"start_date": "2020-02-21",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "reported-late",
"is_pact": false,
"days_late": 103
},
{
"registry_id": "NCT04658940",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04658940",
"title": "AcQBlate Force Sensing Ablation System US IDE for Atrial Flutter (AcQForce Flutter)",
"has_exemption": false,
"start_date": "2021-03-25",
"completion_date": "2022-05-12",
"has_results": true,
"results_due": true,
"sponsor_name": "Acutus Medical",
"sponsor_slug": "acutus-medical",
"status": "reported-late",
"is_pact": false,
"days_late": 90
},
{
"registry_id": "NCT02869789",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02869789",
"title": "A Phase 3b/4 Safety Trial of Flat Dose Nivolumab In Combination With Ipilimumab in Participants With Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2016-10-05",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03525431",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03525431",
"title": "Genomic Sequencing to Aid Diagnosis in Pediatric and Prenatal Practice: Examining Clinical Utility, Ethical Implications, Payer Coverage, and Data Integration in a Diverse Population.",
"has_exemption": false,
"start_date": "2017-08-01",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03482141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03482141",
"title": "Clinical Utility of Prenatal Whole Exome Sequencing",
"has_exemption": false,
"start_date": "2017-08-01",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03174184",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03174184",
"title": "A Phase 2a Study of the Early Bactericidal Activity of Rifampin (RIF) in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampin-resistant or Rifampin-susceptible Pulmonary Tuberculosis",
"has_exemption": false,
"start_date": "2017-08-23",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03915444",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03915444",
"title": "A Phase II Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2019-07-15",
"completion_date": "2022-05-13",
"has_results": false,
"results_due": true,
"sponsor_name": "HonorHealth Research Institute",
"sponsor_slug": "honorhealth-research-institute",
"status": "reported-late",
"is_pact": false,
"days_late": 235
},
{
"registry_id": "NCT03933397",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03933397",
"title": "A Comparison of Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04175834",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04175834",
"title": "Comparing the Risk and Severity of Infusion-Related Reactions in Patients Premedicated With Cetirizine Versus Diphenhydramine Prior to Ocrelizumab Infusions",
"has_exemption": false,
"start_date": "2020-02-05",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Providence Health & Services",
"sponsor_slug": "providence-health-services",
"status": "reported-late",
"is_pact": false,
"days_late": 81
},
{
"registry_id": "NCT04096417",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04096417",
"title": "A Phase II, Multicenter, Single-Arm Study of Pemigatinib in Patients With Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations",
"has_exemption": false,
"start_date": "2020-08-31",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Academic and Community Cancer Research United",
"sponsor_slug": "academic-and-community-cancer-research-united",
"status": "reported-late",
"is_pact": false,
"days_late": 160
},
{
"registry_id": "NCT04191031",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04191031",
"title": "A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen",
"has_exemption": false,
"start_date": "2020-09-30",
"completion_date": "2022-05-13",
"has_results": false,
"results_due": true,
"sponsor_name": "Pacira Pharmaceuticals, Inc",
"sponsor_slug": "pacira-pharmaceuticals-inc",
"status": "overdue",
"is_pact": false,
"days_late": 830
},
{
"registry_id": "NCT04875533",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04875533",
"title": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, THIRD-PARTY-UNBLINDED TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PNEUMOCOCCAL VACCINE-NAÏVE ADULTS 60 YEARS OF AGE AND OLDER IN JAPAN, KOREA, AND TAIWAN",
"has_exemption": false,
"start_date": "2021-06-14",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04884737",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04884737",
"title": "Decreasing Intraoperative Skin Damage in Prone Position Surgeries",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04995419",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04995419",
"title": "A Single-arm, Open-label, Multi-center Phase 2 Study of Enfortumab Vedotin (ASG-22CE) in Chinese Subjects With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Platinum-containing Chemotherapy and PD 1/PD-L1 Inhibitor Therapy (EV-203)",
"has_exemption": false,
"start_date": "2021-07-22",
"completion_date": "2022-05-13",
"has_results": true,
"results_due": true,
"sponsor_name": "Astellas Pharma China, Inc.",
"sponsor_slug": "astellas-pharma-china-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02926235",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02926235",
"title": "Randomized Control Trial of Essential Amino Acid Supplementation in Protein Deficient Patients Following Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2016-04-30",
"completion_date": "2022-05-14",
"has_results": false,
"results_due": true,
"sponsor_name": "Hospital for Special Surgery, New York",
"sponsor_slug": "hospital-for-special-surgery-new-york",
"status": "overdue",
"is_pact": true,
"days_late": 829
},
{
"registry_id": "NCT03968562",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03968562",
"title": "Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline",
"has_exemption": false,
"start_date": "2019-05-15",
"completion_date": "2022-05-14",
"has_results": false,
"results_due": true,
"sponsor_name": "State University of New York - Downstate Medical Center",
"sponsor_slug": "state-university-of-new-york-downstate-medical-center",
"status": "overdue",
"is_pact": false,
"days_late": 829
},
{
"registry_id": "NCT04285580",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04285580",
"title": "An Evaluation of the 24-Hour Intraocular Pressure(IOP)-Lowering Effect of Bimatoprost Sustained-Release(SR) in Participants With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)",
"has_exemption": false,
"start_date": "2020-06-11",
"completion_date": "2022-05-14",
"has_results": true,
"results_due": true,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02297139",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02297139",
"title": "Continuing Treatment for Subjects Who Have Participated on a Prior Protocol Investigating Dasatinib",
"has_exemption": false,
"start_date": "2015-07-31",
"completion_date": "2022-05-15",
"has_results": true,
"results_due": true,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04098068",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04098068",
"title": "Phase 2 Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors",
"has_exemption": false,
"start_date": "2018-01-25",
"completion_date": "2022-05-15",
"has_results": true,
"results_due": true,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03623074",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03623074",
"title": "Efficacy and Safety Study of Novel Spectacle Lens Designs to Control of Myopia",
"has_exemption": false,
"start_date": "2018-07-16",
"completion_date": "2022-05-15",
"has_results": false,
"results_due": true,
"sponsor_name": "SightGlass Vision, Inc.",
"sponsor_slug": "sightglass-vision-inc",
"status": "overdue",
"is_pact": false,
"days_late": 828
},
{
"registry_id": "NCT03937999",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03937999",
"title": "A Pragmatic Trial of Secondary Prophylaxis With Bezlotoxumab to Prevent C. Difficile Relapse Among Hospitalized Adults Receiving Antibiotics.",
"has_exemption": false,
"start_date": "2019-08-30",
"completion_date": "2022-05-15",
"has_results": true,
"results_due": true,
"sponsor_name": "Montefiore Medical Center",
"sponsor_slug": "montefiore-medical-center",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04475081",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04475081",
"title": "Use of a Live Attenuated Vaccine Repurposed as an Innate Immune-based Preventive Against COVID-19-associated Sepsis/Inflammation",
"has_exemption": false,
"start_date": "2020-09-22",
"completion_date": "2022-05-15",
"has_results": true,
"results_due": true,
"sponsor_name": "Louisiana State University Health Sciences Center in New Orleans",
"sponsor_slug": "louisiana-state-university-health-sciences-center-in-new-orleans",
"status": "reported-late",
"is_pact": false,
"days_late": 207
},
{
"registry_id": "NCT02864992",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02864992",
"title": "A Phase II Single-arm Trial to Investigate Tepotinib in Advanced (Locally Advanced or Metastatic) Non-small Cell Lung Cancer With METex14 Skipping Alterations or MET Amplification (VISION)",
"has_exemption": false,
"start_date": "2016-09-13",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "EMD Serono Research & Development Institute, Inc.",
"sponsor_slug": "emd-serono-research-development-institute-inc",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02884206",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02884206",
"title": "A Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Effects of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction",
"has_exemption": false,
"start_date": "2016-11-23",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03239210",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03239210",
"title": "Effects of Ondansetron in Obsessive-compulsive and Tic Disorders",
"has_exemption": false,
"start_date": "2017-06-16",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03502707",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03502707",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study for Safety and Immunogenicity Evaluations for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and Older",
"has_exemption": true,
"start_date": "2018-07-06",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Janssen Vaccines & Prevention B.V.",
"sponsor_slug": "janssen-vaccines-prevention-bv",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04708223",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04708223",
"title": "A 24-Month Clinical Evaluation of an Ultra-rapid Polymerizing Resin Composite",
"has_exemption": false,
"start_date": "2018-09-01",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Ivoclar Vivadent AG",
"sponsor_slug": "ivoclar-vivadent-ag",
"status": "reported-late",
"is_pact": false,
"days_late": 695
},
{
"registry_id": "NCT03828448",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03828448",
"title": "A Phase II Study Evaluating the Safety and Efficacy of Umbralisib (TGR-1202) in Combination With Ublituximab in Patients With Treatment Naïve Follicular Lymphoma and Small Lymphocytic Lymphoma",
"has_exemption": false,
"start_date": "2019-07-10",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04072016",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04072016",
"title": "The Beacon Study: A Prospective, Multicenter Study to Evaluate the Safety and Effectiveness of Beacon Aqueous Microshunt for Refractory Glaucoma",
"has_exemption": false,
"start_date": "2020-04-29",
"completion_date": "2022-05-16",
"has_results": false,
"results_due": true,
"sponsor_name": "MicroOptx",
"sponsor_slug": "microoptx",
"status": "overdue",
"is_pact": false,
"days_late": 827
},
{
"registry_id": "NCT04231318",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04231318",
"title": "A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee",
"has_exemption": false,
"start_date": "2020-09-11",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Anika Therapeutics, Inc.",
"sponsor_slug": "anika-therapeutics-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 30
},
{
"registry_id": "NCT04778592",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04778592",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain",
"has_exemption": false,
"start_date": "2021-01-19",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Eliem Therapeutics (UK) Ltd.",
"sponsor_slug": "eliem-therapeutics-uk-ltd",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04667104",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04667104",
"title": "A Phase 2, Open-label, Single-arm, Multicenter Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Treatment With JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Patients With Chronic Hepatitis B Virus Infection",
"has_exemption": true,
"start_date": "2021-02-01",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04677504",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04677504",
"title": "A Phase II, Randomized, Double-Blind Placebo-Controlled Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer",
"has_exemption": false,
"start_date": "2021-02-23",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04571645",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04571645",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dociparstat Sodium in Combination With Standard Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2021-04-30",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Chimerix",
"sponsor_slug": "chimerix",
"status": "reported-late",
"is_pact": false,
"days_late": 160
},
{
"registry_id": "NCT04881760",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04881760",
"title": "A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities",
"has_exemption": true,
"start_date": "2021-05-20",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04644315",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04644315",
"title": "A Phase II, Open-Label, Single Arm Decentralized Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors",
"has_exemption": false,
"start_date": "2021-05-24",
"completion_date": "2022-05-16",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05036473",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05036473",
"title": "A Phase II Randomized, Parallel, Double-blind, Placebo-controlled, Multi-center Clinical Trial of the Efficacy and Safety of WD-1603 Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease",
"has_exemption": false,
"start_date": "2021-10-12",
"completion_date": "2022-05-16",
"has_results": false,
"results_due": true,
"sponsor_name": "Shanghai WD Pharmaceutical Co., Ltd.",
"sponsor_slug": "shanghai-wd-pharmaceutical-co-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 827
},
{
"registry_id": "NCT01495598",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01495598",
"title": "A Phase I/II Study of the Safety, Pharmacokinetics and Efficacy of Pomalidomide (CC-4047) in the Treatment of Kaposi Sarcoma in Individuals With or Without HIV",
"has_exemption": false,
"start_date": "2012-01-10",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03032406",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03032406",
"title": "CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer",
"has_exemption": false,
"start_date": "2017-01-23",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "reported-late",
"is_pact": false,
"days_late": 505
},
{
"registry_id": "NCT02920892",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02920892",
"title": "Effects of AFQ056 on Language Learning in Young Children With Fragile X Syndrome (FXS)",
"has_exemption": false,
"start_date": "2017-08-17",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Elizabeth Berry-Kravis",
"sponsor_slug": "elizabeth-berry-kravis",
"status": "reported-late",
"is_pact": false,
"days_late": 23
},
{
"registry_id": "NCT03895996",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03895996",
"title": "A Phase 1 / 2 Double-Blind, Randomized, Placebo Controlled Study of Safety, Tolerability and Potential Efficacy of AVOTRES Cell-Based Therapy (AVT001) in Patients With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2019-06-20",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Avotres Inc.",
"sponsor_slug": "avotres-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 421
},
{
"registry_id": "NCT04182451",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04182451",
"title": "A Multi-center, Prospective Clinical Trial Evaluating the Effect of Meso Wound Matrix in the Treatment of Chronic Non-healing Diabetic Foot Ulcers (DFUs).",
"has_exemption": false,
"start_date": "2019-12-05",
"completion_date": "2022-05-17",
"has_results": false,
"results_due": true,
"sponsor_name": "SerenaGroup, Inc.",
"sponsor_slug": "serenagroup-inc",
"status": "overdue",
"is_pact": false,
"days_late": 826
},
{
"registry_id": "NCT04209205",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04209205",
"title": "A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Multicenter Study of Intravenous Secukinumab to Compare Efficacy at 16 Weeks With Placebo and to Assess Safety and Tolerability up to 52 Weeks in Subjects With Active Psoriatic Arthritis",
"has_exemption": true,
"start_date": "2020-01-29",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04278755",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04278755",
"title": "A Mechanistic Examination of Continuous Cycle Oral Contractive Administration in Binge Eating",
"has_exemption": false,
"start_date": "2020-09-24",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04596293",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04596293",
"title": "A Randomised, Double-blind, Placebo-controlled Study of Orally Administered BBT-401-1S in Subjects With Moderate to Severe Ulcerative Colitis, Incorporating a Response-adaptive, Double-blind Extension Phase",
"has_exemption": false,
"start_date": "2021-06-11",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Bridge Biotherapeutics, Inc.",
"sponsor_slug": "bridge-biotherapeutics-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 30
},
{
"registry_id": "NCT05254210",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05254210",
"title": "Feasibility Study To Collect Safety And Preliminary Efficacy Data For A Radiofrequency Microneedling Device",
"has_exemption": false,
"start_date": "2021-09-13",
"completion_date": "2022-05-17",
"has_results": true,
"results_due": true,
"sponsor_name": "Cynosure, Inc.",
"sponsor_slug": "cynosure-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 68
},
{
"registry_id": "NCT02634710",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02634710",
"title": "Pilot Study Evaluating Hypofractionated Pre-operative Radiation Therapy for Soft Tissue Sarcomas of the Extremity and Chest-wall",
"has_exemption": false,
"start_date": "2016-02-23",
"completion_date": "2022-05-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03654976",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03654976",
"title": "A Phase III Trial Evaluating the Efficacy and Safety of the House Dust Mite (HDM) Sublingual Immunotherapy (SLIT)-Tablet in Children and Adolescents (5-17 Years) With HDM Allergic Asthma",
"has_exemption": false,
"start_date": "2018-02-22",
"completion_date": "2022-05-18",
"has_results": true,
"results_due": true,
"sponsor_name": "ALK-Abelló A/S",
"sponsor_slug": "alk-abello-as",
"status": "reported-late",
"is_pact": false,
"days_late": 8
},
{
"registry_id": "NCT03926143",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03926143",
"title": "An Open-label, Multicenter Rollover Study to Provide Continued Treatment With Anetumab Ravtansine for Participants With Solid Tumors Who Were Enrolled in Previous Bayer-sponsored Studies",
"has_exemption": false,
"start_date": "2019-06-03",
"completion_date": "2022-05-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03805659",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03805659",
"title": "High-Definition Transcranial Direct Current Stimulation (HD-tDCS) in Logopenic Variant Primary Progressive Aphasia (lvPPA): Effects on Language and Neural Mechanisms",
"has_exemption": false,
"start_date": "2020-02-24",
"completion_date": "2022-05-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "reported-late",
"is_pact": false,
"days_late": 82
},
{
"registry_id": "NCT04895618",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04895618",
"title": "An Evaluation of the Effect of the Erchonia® GVL Green and Violet Laser on Neck and Shoulder Pain",
"has_exemption": false,
"start_date": "2020-11-11",
"completion_date": "2022-05-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Erchonia Corporation",
"sponsor_slug": "erchonia-corporation",
"status": "reported-late",
"is_pact": false,
"days_late": 55
},
{
"registry_id": "NCT04706975",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04706975",
"title": "A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Adult Subjects With Notalgia Paresthetica",
"has_exemption": true,
"start_date": "2021-01-11",
"completion_date": "2022-05-18",
"has_results": false,
"results_due": true,
"sponsor_name": "Cara Therapeutics, Inc.",
"sponsor_slug": "cara-therapeutics-inc",
"status": "overdue",
"is_pact": false,
"days_late": 94
},
{
"registry_id": "NCT05074433",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05074433",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Anti-Spike SARS-CoV-2 Monoclonal Antibodies as Pre-Exposure Prophylaxis to Prevent COVID-19 in Immunocompromised Participants",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2022-05-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05276401",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05276401",
"title": "A Phase 2a, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Dose Escalating Study to Evaluate the Safety and Tolerability of Topically Applied Bisphosphocin Nu-3 Gel to Clinically Noninfected Chronic Diabetic Foot Ulcers (cDFU)",
"has_exemption": false,
"start_date": "2022-03-11",
"completion_date": "2022-05-18",
"has_results": true,
"results_due": true,
"sponsor_name": "Lakewood-Amedex Inc",
"sponsor_slug": "lakewood-amedex-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 210
},
{
"registry_id": "NCT01819831",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01819831",
"title": "A Phase II Trial of Preoperative Proton Therapy in Soft-tissue Sarcomas of the Extremities and Body Wall",
"has_exemption": false,
"start_date": "2013-02-27",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "reported-late",
"is_pact": true,
"days_late": 7
},
{
"registry_id": "NCT02098161",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02098161",
"title": "Open Label Phase 2 Single Agent Study of LCL-161 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)",
"has_exemption": false,
"start_date": "2014-12-18",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03106415",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03106415",
"title": "Phase I/II Trial of Pembrolizumab in Combination With Binimetinib in Unresectable Locally Advanced or Metastatic Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2017-09-27",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported-late",
"is_pact": false,
"days_late": 216
},
{
"registry_id": "NCT03324880",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03324880",
"title": "A Randomized, Double-blind, Placebo-controlled, Adaptive Study to Evaluate Symptom Improvement and Metabolic Control Among Adult Subjects With Symptomatic Hypoparathyroidism Treated With Recombinant Human Parathyroid Hormone [rhPTH(1-84)]",
"has_exemption": false,
"start_date": "2018-01-24",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Shire",
"sponsor_slug": "shire",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03919669",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03919669",
"title": "Longitudinal Evaluation of [18-F]MK-6240 as a Novel Tau PET Radiotracer in Patients With Alzheimer's Disease Dementia or Mild Cognitive Impairment Compared to Healthy Volunteers",
"has_exemption": false,
"start_date": "2019-04-02",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04002037",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04002037",
"title": "Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis: A Double-Blind Prospective Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2019-06-25",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Missouri-Columbia",
"sponsor_slug": "university-of-missouri-columbia",
"status": "reported-late",
"is_pact": false,
"days_late": 199
},
{
"registry_id": "NCT03847090",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03847090",
"title": "Establishing the Safety and Efficacy of Reloxaliase (Oxalate Decarboxylase) in Patients With Enteric Hyperoxaluria: A Phase III Randomized, Double-Blind, Placebo-Controlled Study (URIROX-2)",
"has_exemption": false,
"start_date": "2019-08-26",
"completion_date": "2022-05-19",
"has_results": false,
"results_due": true,
"sponsor_name": "Allena Pharmaceuticals",
"sponsor_slug": "allena-pharmaceuticals",
"status": "overdue",
"is_pact": false,
"days_late": 824
},
{
"registry_id": "NCT04092582",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04092582",
"title": "A Phase IIa, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller",
"has_exemption": false,
"start_date": "2019-10-31",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04538950",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04538950",
"title": "PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy",
"has_exemption": false,
"start_date": "2020-08-14",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported-late",
"is_pact": false,
"days_late": 60
},
{
"registry_id": "NCT04541186",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04541186",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of BIO89-100 in Subjects With Severe Hypertriglyceridemia",
"has_exemption": false,
"start_date": "2020-09-01",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "89bio, Inc.",
"sponsor_slug": "89bio-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 355
},
{
"registry_id": "NCT04638660",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04638660",
"title": "Randomized, Placebo-Controlled, Double-Masked Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances",
"has_exemption": false,
"start_date": "2020-12-30",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Ocuphire Pharma, Inc.",
"sponsor_slug": "ocuphire-pharma-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 48
},
{
"registry_id": "NCT04817111",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04817111",
"title": "A Phase 2a Study of NAD+ Precursor Supplementation in Friedreich's Ataxia",
"has_exemption": false,
"start_date": "2021-05-17",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Metro International Biotech, LLC",
"sponsor_slug": "metro-international-biotech-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04764929",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04764929",
"title": "Helmet CPAP for Infants and Pediatric Patients With Acute Respiratory Distress",
"has_exemption": false,
"start_date": "2021-08-07",
"completion_date": "2022-05-19",
"has_results": true,
"results_due": true,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "reported-late",
"is_pact": false,
"days_late": 368
},
{
"registry_id": "NCT01538966",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01538966",
"title": "Comparison of Combination Low-Dose SRL + Daily Pegvisomant Therapy, Low-Dose SRL + Weekly Pegvisomant Therapy, and High-Dose SRL + Weekly Pegvisomant Therapy",
"has_exemption": false,
"start_date": "2012-03-29",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02960659",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02960659",
"title": "Therapeutic Targets in African-American Youth With Type 2 Diabetes",
"has_exemption": false,
"start_date": "2017-05-09",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03043053",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03043053",
"title": "A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Repeat Doses of Intranasal Oxytocin in Obese Adults",
"has_exemption": true,
"start_date": "2017-07-01",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03702244",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03702244",
"title": "Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization",
"has_exemption": false,
"start_date": "2018-11-27",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "HeartFlow, Inc.",
"sponsor_slug": "heartflow-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 111
},
{
"registry_id": "NCT04085458",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04085458",
"title": "Post-marketing Investigation (PMI) to Assess Safety and Efficacy of Jivi (BAY 94-9027) Treatment in Participants With Hemophilia A",
"has_exemption": false,
"start_date": "2019-09-23",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04417140",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04417140",
"title": "A Prospective, Double-Blinded, Randomized Controlled Trial of Dehydrated Human Amniotic-Chorionic Membrane for Incisional Hernia Prophylaxis",
"has_exemption": false,
"start_date": "2020-05-20",
"completion_date": "2022-05-20",
"has_results": false,
"results_due": true,
"sponsor_name": "Louisiana State University Health Sciences Center in New Orleans",
"sponsor_slug": "louisiana-state-university-health-sciences-center-in-new-orleans",
"status": "overdue",
"is_pact": false,
"days_late": 823
},
{
"registry_id": "NCT04429334",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04429334",
"title": "Efficacy and Safety Study Exploring Nangibotide Treatment in COVID-19 pAtients With ventiLatory Support (ESSENTIAL) A Randomized, Double-blind, Placebo-controlled Study With Adaptive Features",
"has_exemption": false,
"start_date": "2020-09-23",
"completion_date": "2022-05-20",
"has_results": false,
"results_due": true,
"sponsor_name": "Inotrem",
"sponsor_slug": "inotrem",
"status": "reported-late",
"is_pact": false,
"days_late": 605
},
{
"registry_id": "NCT05399212",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05399212",
"title": "A New Natural Origin Product, Achieving More Than 80% Efficiency in Spermatogenesis in the Seminiferous Tubules. This Method Opens up Hope for Cases of Infertility Caused by the Inability of Spermatogonia to Develop Into Mature Sperm.",
"has_exemption": false,
"start_date": "2020-10-29",
"completion_date": "2022-05-20",
"has_results": false,
"results_due": true,
"sponsor_name": "Triệu, Nguyễn Thị, M.D.",
"sponsor_slug": "trieu-nguyen-thi-md",
"status": "overdue",
"is_pact": false,
"days_late": 823
},
{
"registry_id": "NCT04491006",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04491006",
"title": "A Randomized, Placebo-Controlled, Translational Study of ATH-1017 in Subjects With Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2020-11-23",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Athira Pharma",
"sponsor_slug": "athira-pharma",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04272489",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04272489",
"title": "Efficacy of Control System Adaptation in Improving Upper-Extremity Prosthetic Limb Wear Time in a Real-World Setting, a Randomized Crossover Trial",
"has_exemption": false,
"start_date": "2020-12-17",
"completion_date": "2022-05-20",
"has_results": false,
"results_due": true,
"sponsor_name": "Coapt, LLC",
"sponsor_slug": "coapt-llc",
"status": "overdue",
"is_pact": false,
"days_late": 823
},
{
"registry_id": "NCT04487860",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04487860",
"title": "A Phase II, Randomized, Double Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo",
"has_exemption": true,
"start_date": "2021-01-13",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Ache Laboratorios Farmaceuticos S.A.",
"sponsor_slug": "ache-laboratorios-farmaceuticos-sa",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04562597",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04562597",
"title": "A Pilot Trial to Determine the Effective Dose of N-acetylcysteine for Opioid Reduction in Patients Undergoing Spine Surgery.",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04684576",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04684576",
"title": "Early Powered Mobility for Toddlers With Cerebral Palsy: A Comparative Case Series of the Permobil® Explorer Mini and a Modified Ride-On Car",
"has_exemption": false,
"start_date": "2021-04-15",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04954326",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04954326",
"title": "A Multicentre, Phase II Randomized Study, Open-label, With 2-arm Parallel Group, Comparing the Pharmacokinetics of the Liquid and the Lyophilized Formulations of Pegaspargase (S95014) in Treatment of Paediatric Patients With Newly-Diagnosed Acute Lymphoblastic Leukemia (ALL)",
"has_exemption": false,
"start_date": "2021-05-07",
"completion_date": "2022-05-20",
"has_results": true,
"results_due": true,
"sponsor_name": "Institut de Recherches Internationales Servier",
"sponsor_slug": "institut-de-recherches-internationales-servier",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04035187",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04035187",
"title": "Prediction of Itraconazole Oral Absorption From In Vitro Dissolution",
"has_exemption": false,
"start_date": "2020-02-10",
"completion_date": "2022-05-21",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "reported-late",
"is_pact": false,
"days_late": 113
},
{
"registry_id": "NCT04422431",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04422431",
"title": "A Phase 2, Single-arm Pathologist-blinded 48-week Study Using Liver Biopsy Specimens to Assess Copper Concentration and Histopathologic Changes in ALXN1840-treated Patients With Wilson Disease Followed by an up to 48-weeks Extension Period",
"has_exemption": false,
"start_date": "2020-12-02",
"completion_date": "2022-05-21",
"has_results": true,
"results_due": true,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04547556",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04547556",
"title": "ADEQUATE Advanced Diagnostics for Enhanced QUality of Antibiotic Prescription in Respiratory Tract Infections in Emergency Rooms",
"has_exemption": false,
"start_date": "2021-10-25",
"completion_date": "2022-05-21",
"has_results": true,
"results_due": true,
"sponsor_name": "UMC Utrecht",
"sponsor_slug": "umc-utrecht",
"status": "reported-late",
"is_pact": false,
"days_late": 215
},
{
"registry_id": "NCT03584854",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03584854",
"title": "Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2019-03-01",
"completion_date": "2022-05-22",
"has_results": false,
"results_due": true,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "reported-late",
"is_pact": false,
"days_late": 372
},
{
"registry_id": "NCT03779711",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03779711",
"title": "Phase IIb Study of Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Stage II Surgical Repair of Right Ventricular Dependent Variants of Hypoplastic Left Heart Syndrome (AutoCell-S2)",
"has_exemption": false,
"start_date": "2019-06-06",
"completion_date": "2022-05-22",
"has_results": true,
"results_due": true,
"sponsor_name": "Timothy J Nelson, MD, PhD",
"sponsor_slug": "timothy-j-nelson-md-phd",
"status": "reported-late",
"is_pact": false,
"days_late": 592
},
{
"registry_id": "NCT03911908",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03911908",
"title": "Impact of a NIRS-guided Cardiopulmonary Resuscitation Algorithm Compared to the Current ERC-guideline Algorithm on ROSC Rate and Patient Outcome After In-hospital and Out-of-hospital Cardiac Arrest",
"has_exemption": false,
"start_date": "2019-07-01",
"completion_date": "2022-05-22",
"has_results": false,
"results_due": true,
"sponsor_name": "Dr. Serge Thal",
"sponsor_slug": "dr-serge-thal",
"status": "overdue",
"is_pact": false,
"days_late": 821
},
{
"registry_id": "NCT04016805",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04016805",
"title": "A Phase 2 Study to Assess the Efficacy and Safety of Ublituximab and Umbralisib in Subjects With Chronic Lymphocytic Leukemia (CLL) Currently Treated With Ibrutinib, Acalabrutinib or Venetoclax",
"has_exemption": false,
"start_date": "2019-08-05",
"completion_date": "2022-05-22",
"has_results": true,
"results_due": true,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03077451",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03077451",
"title": "A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2017-03-13",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "AIDS Malignancy Consortium",
"sponsor_slug": "aids-malignancy-consortium",
"status": "reported-late",
"is_pact": false,
"days_late": 10
},
{
"registry_id": "NCT03548584",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03548584",
"title": "A Phase 3, 12-Week, Multicenter, Randomized, Double-blind, Placebo-controlled, 2-Arm, Fixed-dose Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type",
"has_exemption": false,
"start_date": "2018-05-16",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 8
},
{
"registry_id": "NCT03601897",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03601897",
"title": "An Open-Label, Multicenter, Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2018-10-25",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Deciphera Pharmaceuticals LLC",
"sponsor_slug": "deciphera-pharmaceuticals-llc",
"status": "reported-late",
"is_pact": false,
"days_late": 560
},
{
"registry_id": "NCT03756454",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03756454",
"title": "A Prospective, Double-blind, Randomized, and Controlled Clinical Trial to Compare the Effectiveness of Intravenous Bezlotoxumab (10 mg/kg) Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant Clostridioides Difficile Requiring Surgical Intervention.",
"has_exemption": false,
"start_date": "2019-08-19",
"completion_date": "2022-05-23",
"has_results": false,
"results_due": true,
"sponsor_name": "Michael E Villarreal, MD",
"sponsor_slug": "michael-e-villarreal-md",
"status": "reported-late",
"is_pact": false,
"days_late": 157
},
{
"registry_id": "NCT03774394",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03774394",
"title": "Impact of Chronic Kidney Disease (CKD) on Pharmacodynamic Profiles of the P2Y12 Receptor Inhibitor Clopidogrel in the Setting of Type 2 Diabetes Mellitus (T2DM) and Coronary Artery Disease (CAD)",
"has_exemption": false,
"start_date": "2019-08-22",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "reported-late",
"is_pact": false,
"days_late": 37
},
{
"registry_id": "NCT04455633",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04455633",
"title": "A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of LX9211 in the Treatment of Diabetic Peripheral Neuropathic Pain",
"has_exemption": true,
"start_date": "2020-09-03",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Lexicon Pharmaceuticals",
"sponsor_slug": "lexicon-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04084210",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04084210",
"title": "Understanding the Real-World Impact of the Use of Three Alternate Nicotine-Delivery Products on Combustible Cigarette Use",
"has_exemption": false,
"start_date": "2020-09-09",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04590248",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04590248",
"title": "A Phase 2b, Open-label, Single-arm, Multi-centre Study Assessing the Efficacy and Safety of Adavosertib as Treatment for Recurrent or Persistent Uterine Serous Carcinoma",
"has_exemption": false,
"start_date": "2020-11-30",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04660799",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04660799",
"title": "A Phase II Comparative, Open-Label, Randomized, Multicenter, China-Only Study to Investigate the Pharmacokinetics, Efficacy and Safety of Subcutaneous Rituximab Versus Intravenous Rituximab Both in Combination With CHOP in Previously Untreated Patients With CD20 Positive Diffuse Large B Cell Lymphoma",
"has_exemption": false,
"start_date": "2021-02-24",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05011123",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05011123",
"title": "Controlled Study of Immunogenicity and Safety of the Investigational vYF Candidate Vaccine in Comparison to Stamaril in Adults",
"has_exemption": true,
"start_date": "2021-10-07",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Sanofi Pasteur, a Sanofi Company",
"sponsor_slug": "sanofi-pasteur-a-sanofi-company",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05227300",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05227300",
"title": "Buffered vs. Unbuffered Local Anesthesia in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis: A Controlled, Randomized Double-blind Study",
"has_exemption": false,
"start_date": "2022-02-14",
"completion_date": "2022-05-23",
"has_results": true,
"results_due": true,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01389024",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01389024",
"title": "Hydroxyurea to Prevent Central Nervous System (CNS) Complications of Sickle Cell Disease in Children",
"has_exemption": false,
"start_date": "2012-08-16",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01712308",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01712308",
"title": "A Phase-2, Prospective, Open-Label Study to Determine the Safety and Efficacy of Sotatercept (ACE-011) in Subjects With Myeloproliferative Neoplasm (MPN) -Associated Myelofibrosis and Anemia",
"has_exemption": false,
"start_date": "2013-02-21",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02864147",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02864147",
"title": "Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) Using a Novel \"Prime and Pull\" Strategy",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "reported-late",
"is_pact": true,
"days_late": 232
},
{
"registry_id": "NCT02798471",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02798471",
"title": "A Phase 3, Open-label, Randomized, Multi-center, Controlled Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Edoxaban and to Compare the Efficacy and Safety of Edoxaban With Standard of Care Anticoagulant Therapy in Pediatric Subjects From Birth to Less Than 18 Years of Age With Confirmed Venous Thromboembolism (VTE)",
"has_exemption": false,
"start_date": "2017-03-27",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03182751",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03182751",
"title": "Does Early Administration of Tranexamic Acid Reduce Blood Loss and Perioperative Transfusion Requirement in Low Energy Hip Fracture Patients?",
"has_exemption": false,
"start_date": "2018-04-02",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03601507",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03601507",
"title": "Biomarker Modulation by Alpelisib (BYL719) in Transorally Resectable, HPV-Associated HNSCC: A Phase II Window Trial",
"has_exemption": true,
"start_date": "2019-03-11",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04093024",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04093024",
"title": "A Double Blind, Randomised, Placebo-controlled Trial to Evaluate the Dose-exposure and Safety of Nintedanib Per os on Top of Standard of Care for 24 Weeks, Followed by Open Label Treatment With Nintedanib of Variable Duration, in Children and Adolescents (6 to 17 Year-old) With Clinically Significant Fibrosing Interstitial Lung Disease",
"has_exemption": false,
"start_date": "2019-12-03",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04072822",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04072822",
"title": "A Multicenter, Randomized, Double Blinded, Placebo-controlled Clinical Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis by the AlcHepNet Consortium",
"has_exemption": false,
"start_date": "2020-07-10",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04532749",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04532749",
"title": "A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy",
"has_exemption": true,
"start_date": "2020-09-15",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04556617",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04556617",
"title": "A Multicenter, Open-Label, Parallel, Phase 1b/2a Study of PLX2853 in Combination With Abiraterone Acetate and Prednisone and Phase 1b/2a Study of PLX2853 in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2020-09-21",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Opna Bio LLC",
"sponsor_slug": "opna-bio-llc",
"status": "reported-late",
"is_pact": false,
"days_late": 241
},
{
"registry_id": "NCT04659161",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04659161",
"title": "A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adults With DSM-5 Schizophrenia",
"has_exemption": false,
"start_date": "2020-12-16",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Karuna Therapeutics",
"sponsor_slug": "karuna-therapeutics",
"status": "reported-late",
"is_pact": false,
"days_late": 156
},
{
"registry_id": "NCT04818346",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04818346",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Efficacy and Safety of INCB054707 Followed by an Extension Period in Participants With Vitiligo",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2022-05-24",
"has_results": true,
"results_due": true,
"sponsor_name": "Incyte Corporation",
"sponsor_slug": "incyte-corporation",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02759835",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02759835",
"title": "A Pilot Study of Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-mutated, Non-Small Cell Lung Cancer (NSCLC) After Treatment With Osimertinib (AZD9291, Tagrisso)",
"has_exemption": false,
"start_date": "2016-04-13",
"completion_date": "2022-05-25",
"has_results": true,
"results_due": true,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03207256",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03207256",
"title": "An Open Label Extension Trial of Ublituximab and/or Umbralisib (TGR-1202) in Combination With Other Novel Agents or as Single Agents in Subjects Currently Receiving Treatment on a TG Therapeutics Study.",
"has_exemption": false,
"start_date": "2017-08-09",
"completion_date": "2022-05-25",
"has_results": false,
"results_due": true,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03740763",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03740763",
"title": "Treatment of Neuropathic Pain With Spinal Cord Stimulation and Physiotherapy for More Effective Pain Relief, Increased Physical Activity and Improved Health Related Quality of Life",
"has_exemption": false,
"start_date": "2018-05-09",
"completion_date": "2022-05-25",
"has_results": false,
"results_due": true,
"sponsor_name": "Göteborg University",
"sponsor_slug": "goteborg-university",
"status": "overdue",
"is_pact": false,
"days_late": 818
},
{
"registry_id": "NCT03712098",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03712098",
"title": "Glucagon-like Peptide-1 Receptor Agonists as Novel Pharmacotherapies for Nicotine Dependence",
"has_exemption": true,
"start_date": "2018-11-29",
"completion_date": "2022-05-25",
"has_results": true,
"results_due": true,
"sponsor_name": "Rebecca Ashare",
"sponsor_slug": "rebecca-ashare",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03779048",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03779048",
"title": "Use of Pharmacotherapy to Improve Weight Loss in Early Non-responders to Behavioral Treatment",
"has_exemption": false,
"start_date": "2019-07-15",
"completion_date": "2022-05-25",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04042233",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04042233",
"title": "Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol",
"has_exemption": false,
"start_date": "2019-12-31",
"completion_date": "2022-05-25",
"has_results": true,
"results_due": true,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "reported-late",
"is_pact": false,
"days_late": 291
},
{
"registry_id": "NCT05428020",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05428020",
"title": "The Use of a Routine Indwelling Urinary Catheter in Patients Receiving Neuraxial Anesthesia for Elective Total Joint Arthroplasty",
"has_exemption": false,
"start_date": "2020-11-16",
"completion_date": "2022-05-25",
"has_results": true,
"results_due": true,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "reported-late",
"is_pact": false,
"days_late": 27
},
{
"registry_id": "NCT04351373",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04351373",
"title": "Microscopic Fluorescence-guided Vestibular Schwannoma, Meningioma, Head and Neck Paraganglioma, or Head and Neck Schwannoma Resection Using Fluorescein Sodium and YELLOW 560",
"has_exemption": false,
"start_date": "2021-10-06",
"completion_date": "2022-05-25",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported-late",
"is_pact": false,
"days_late": 48
},
{
"registry_id": "NCT05079126",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05079126",
"title": "Double-Blind, Placebo-Controlled Study of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease",
"has_exemption": false,
"start_date": "2021-12-02",
"completion_date": "2022-05-25",
"has_results": false,
"results_due": true,
"sponsor_name": "Diffusion Pharmaceuticals Inc",
"sponsor_slug": "diffusion-pharmaceuticals-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05300763",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05300763",
"title": "Clinical Performance of Senofilcon A Investigational Lens",
"has_exemption": false,
"start_date": "2022-03-21",
"completion_date": "2022-05-25",
"has_results": true,
"results_due": true,
"sponsor_name": "Johnson & Johnson Vision Care, Inc.",
"sponsor_slug": "johnson-johnson-vision-care-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02656303",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02656303",
"title": "A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination With Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304",
"has_exemption": false,
"start_date": "2016-01-07",
"completion_date": "2022-05-26",
"has_results": true,
"results_due": true,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03374956",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03374956",
"title": "Individualized Pharmacological Approach to Obesity Management: A Randomized Clinical Trial",
"has_exemption": false,
"start_date": "2017-12-11",
"completion_date": "2022-05-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03379051",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03379051",
"title": "Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL",
"has_exemption": false,
"start_date": "2018-03-27",
"completion_date": "2022-05-26",
"has_results": false,
"results_due": true,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03418129",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03418129",
"title": "Neuromodulatory Treatments for Pain Management in Veterans With Complex TBI Using Mobile Technology",
"has_exemption": false,
"start_date": "2018-09-05",
"completion_date": "2022-05-26",
"has_results": true,
"results_due": true,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03893539",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03893539",
"title": "PRECIsE: A Prospective Evaluation of the Clinical Utility for the Ion Endoluminal System",
"has_exemption": false,
"start_date": "2019-03-29",
"completion_date": "2022-05-26",
"has_results": false,
"results_due": true,
"sponsor_name": "Intuitive Surgical",
"sponsor_slug": "intuitive-surgical",
"status": "overdue",
"is_pact": false,
"days_late": 817
},
{
"registry_id": "NCT04242173",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04242173",
"title": "A Single Arm Phase II Study of Cemiplimab-rwlc in Immunocompromised Patients With Unresectable Locally Recurrent and/or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)",
"has_exemption": false,
"start_date": "2020-06-25",
"completion_date": "2022-05-26",
"has_results": true,
"results_due": true,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04331080",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04331080",
"title": "A Phase 2b/3 Randomized, Prospective, Double Blind, Within-Subject Vehicle Controlled, Multi-Center Study to Determine the Efficacy and Safety of Granexin® Gel in Reducing Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery",
"has_exemption": false,
"start_date": "2020-07-01",
"completion_date": "2022-05-26",
"has_results": false,
"results_due": true,
"sponsor_name": "Xequel Bio, Inc.",
"sponsor_slug": "xequel-bio-inc",
"status": "overdue",
"is_pact": false,
"days_late": 817
},
{
"registry_id": "NCT04594941",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04594941",
"title": "A Descriptive, Comparative, Randomized, Crossover Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion Imaging Quality Using High Performance Liquid Chromatography (HPLC) and Solid Phase Extraction (SPE) Manufacturing Processes",
"has_exemption": false,
"start_date": "2022-01-27",
"completion_date": "2022-05-26",
"has_results": true,
"results_due": true,
"sponsor_name": "GE Healthcare",
"sponsor_slug": "ge-healthcare",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01791543",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01791543",
"title": "Early Feasibility Study of Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation",
"has_exemption": false,
"start_date": "2016-09-30",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "William Stevenson",
"sponsor_slug": "william-stevenson",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02859064",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02859064",
"title": "A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres (SIR-Spheres®)",
"has_exemption": false,
"start_date": "2017-07-28",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "SCRI Development Innovations, LLC",
"sponsor_slug": "scri-development-innovations-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03181893",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03181893",
"title": "A PHASE 2 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF PF-06823859 IN ADULT SUBJECTS WITH DERMATOMYOSITIS",
"has_exemption": false,
"start_date": "2018-01-23",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03493919",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03493919",
"title": "A Sourcing Study to Collect Human Biological (Serum) Samples From Healthy Adults",
"has_exemption": false,
"start_date": "2018-03-08",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03827655",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03827655",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of 2 Dose Regimens of Intravenous TAK-954 for the Prophylaxis and Treatment of Postoperative Gastrointestinal Dysfunction in Patients Undergoing Large- and Small-Bowel Resection",
"has_exemption": false,
"start_date": "2019-03-07",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04030026",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04030026",
"title": "A Phase 2, Double-blind, Randomized, Placebo-controlled, Two-Treatment, Two-Period Crossover Efficacy and Safety Study in Idiopathic Pulmonary Fibrosis (IPF) With Nalbuphine ER Tablets for the Treatment of Cough",
"has_exemption": true,
"start_date": "2019-10-29",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Trevi Therapeutics",
"sponsor_slug": "trevi-therapeutics",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03801915",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03801915",
"title": "Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers",
"has_exemption": false,
"start_date": "2019-11-13",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04134494",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04134494",
"title": "Effectiveness of Ablative Fractional 2940 nm Laser Treatment for Vulvar Lichen Sclerosus",
"has_exemption": false,
"start_date": "2020-01-01",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Beth Israel Deaconess Medical Center",
"sponsor_slug": "beth-israel-deaconess-medical-center",
"status": "reported-late",
"is_pact": false,
"days_late": 48
},
{
"registry_id": "NCT04348591",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04348591",
"title": "Identifying the Optimal Neural Target for Misophonia Interventions",
"has_exemption": false,
"start_date": "2020-10-28",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04904809",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04904809",
"title": "Perclose Multi-Access DUS Study: Assess the Safety and Performance of the Perclose ProGlide™ Suture-Mediated Closure (SMC) System and the Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System in Managing Multiple Venous Access Sites (Evaluation by DUS)",
"has_exemption": false,
"start_date": "2021-09-01",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Abbott Medical Devices",
"sponsor_slug": "abbott-medical-devices",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05291936",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05291936",
"title": "Clinical Evaluation of Two Daily Disposable Toric Soft Contact Lenses Over One Week of Wear",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "Johnson & Johnson Vision Care, Inc.",
"sponsor_slug": "johnson-johnson-vision-care-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05325853",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05325853",
"title": "A Randomized, Single-Masked, Active-Controlled, Parallel-Group Evaluation of Safety and the Local Anesthetic Effect of Articaine Sterile Topical Ophthalmic Solution (AG-920) in a Pediatric Population",
"has_exemption": false,
"start_date": "2022-04-06",
"completion_date": "2022-05-27",
"has_results": true,
"results_due": true,
"sponsor_name": "American Genomics, LLC",
"sponsor_slug": "american-genomics-llc",
"status": "reported-late",
"is_pact": false,
"days_late": 127
},
{
"registry_id": "NCT03897205",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03897205",
"title": "A Randomized, Open-Label, Multi-Centre, Active Control, Efficacy and Safety Study of Imlifidase in Eliminating Donor Specific Anti-HLA Antibodies in the Treatment of Active Antibody-Mediated Rejection in Kidney Transplant Patients",
"has_exemption": false,
"start_date": "2019-04-30",
"completion_date": "2022-05-28",
"has_results": true,
"results_due": true,
"sponsor_name": "Hansa Biopharma AB",
"sponsor_slug": "hansa-biopharma-ab",
"status": "reported-late",
"is_pact": false,
"days_late": 134
},
{
"registry_id": "NCT04663282",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04663282",
"title": "Evaluation of the Efficacy and Safety of INS068 Injection and Insulin Degludec Subcutaneous Injection Once Daily in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With One or Two Oral Antidiabetics (A Randomized, Open-Label, Two-Arm, Treat-to-Target, Parallel Controlled Trial)",
"has_exemption": false,
"start_date": "2021-02-04",
"completion_date": "2022-05-28",
"has_results": false,
"results_due": true,
"sponsor_name": "Jiangsu HengRui Medicine Co., Ltd.",
"sponsor_slug": "jiangsu-hengrui-medicine-co-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 815
},
{
"registry_id": "NCT04460885",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04460885",
"title": "A 78-week Trial Comparing the Effect and Safety of Once Weekly Insulin Icodec and Once Daily Insulin Glargine 100 Units/mL, Both in Combination With Non-insulin Anti-diabetic Treatment, in Insulin naïve Subjects With Type 2 Diabetes",
"has_exemption": true,
"start_date": "2020-11-25",
"completion_date": "2022-05-29",
"has_results": true,
"results_due": true,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05487404",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05487404",
"title": "A Double-Blind Clinical Trial to Assess the Interaction Between ADX-629 and Ethanol While Exploring the Safety, Tolerability, and Activity of ADX-629 in Subjects With Elevated Ethanol Levels",
"has_exemption": false,
"start_date": "2021-11-15",
"completion_date": "2022-05-29",
"has_results": true,
"results_due": true,
"sponsor_name": "Aldeyra Therapeutics, Inc.",
"sponsor_slug": "aldeyra-therapeutics-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 618
},
{
"registry_id": "NCT05625477",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05625477",
"title": "A Multicenter, Randomized, Double-Blind, Parallel-Controlled, Dose-Finding Phase II Study to Compare the Anti-tetanus Neutralizing Antibody Titers and Safety of TNM002 Injection With Human Tetanus Immunoglobulin or Placebo Following a Single Intramuscular Injection in Chinese Adult Volunteers",
"has_exemption": true,
"start_date": "2022-04-18",
"completion_date": "2022-05-29",
"has_results": false,
"results_due": true,
"sponsor_name": "Zhuhai Trinomab Pharmaceutical Co., Ltd.",
"sponsor_slug": "zhuhai-trinomab-pharmaceutical-co-ltd",
"status": "reported-late",
"is_pact": false,
"days_late": 24
},
{
"registry_id": "NCT04490993",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04490993",
"title": "A Multi-center, Randomized, Double-blind, Placebo-controlled Phase Ⅲ Clinical Trial to Evaluate the Clinical Safety and Efficacy of APL-1202 in Combination With Epirubicin Hydrochloride Versus Epirubicin Hydrochloride Alone in Intermediate and High-risk Chemo-refractory Non-muscle Invasive Bladder Cancer (NMIBC) Patients",
"has_exemption": false,
"start_date": "2017-03-30",
"completion_date": "2022-05-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Jiangsu Yahong Meditech Co., Ltd aka Asieris",
"sponsor_slug": "jiangsu-yahong-meditech-co-ltd-aka-asieris",
"status": "overdue",
"is_pact": false,
"days_late": 813
},
{
"registry_id": "NCT03139747",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03139747",
"title": "UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone",
"has_exemption": false,
"start_date": "2017-04-03",
"completion_date": "2022-05-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "overdue",
"is_pact": false,
"days_late": 813
},
{
"registry_id": "NCT03215927",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03215927",
"title": "A Randomized, Controlled Pilot Trial to Evaluate the Efficacy and Safety of Subcutaneous Abatacept in Treating Interstitial Lung Disease Associated With the Anti-synthetase Syndrome",
"has_exemption": false,
"start_date": "2018-01-01",
"completion_date": "2022-05-30",
"has_results": true,
"results_due": true,
"sponsor_name": "Rohit Aggarwal, MD",
"sponsor_slug": "rohit-aggarwal-md",
"status": "reported-late",
"is_pact": false,
"days_late": 36
},
{
"registry_id": "NCT02733029",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02733029",
"title": "Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection",
"has_exemption": false,
"start_date": "2018-05-30",
"completion_date": "2022-05-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "overdue",
"is_pact": false,
"days_late": 813
},
{
"registry_id": "NCT04233229",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04233229",
"title": "Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 Diabetes: a Randomized Controlled Trial vs Usual Care",
"has_exemption": false,
"start_date": "2019-12-30",
"completion_date": "2022-05-30",
"has_results": true,
"results_due": true,
"sponsor_name": "Air Liquide Santé International",
"sponsor_slug": "air-liquide-sante-international",
"status": "reported-late",
"is_pact": false,
"days_late": 653
},
{
"registry_id": "NCT04429503",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04429503",
"title": "A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients With Diabetic Macular Edema",
"has_exemption": true,
"start_date": "2020-06-29",
"completion_date": "2022-05-30",
"has_results": true,
"results_due": true,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04963062",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04963062",
"title": "Randomized Clinical Trial Evaluating the Efficiency and Safety of Holmium Laser With Moses Technology Versus SuperPulsed Laser System With Thulium Laser on Renal and Ureteral Stones",
"has_exemption": false,
"start_date": "2021-07-16",
"completion_date": "2022-05-30",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05853185",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05853185",
"title": "Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.",
"has_exemption": false,
"start_date": "2021-10-12",
"completion_date": "2022-05-30",
"has_results": true,
"results_due": true,
"sponsor_name": "Liaquat University of Medical & Health Sciences",
"sponsor_slug": "liaquat-university-of-medical-health-sciences",
"status": "reported-late",
"is_pact": false,
"days_late": 2
},
{
"registry_id": "NCT05070767",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05070767",
"title": "Randomized Controlled Double Masked Two Arm Cross-over Study of Neurolenses in Subjects With Headaches",
"has_exemption": false,
"start_date": "2021-10-18",
"completion_date": "2022-05-30",
"has_results": false,
"results_due": true,
"sponsor_name": "Neurolens Inc.",
"sponsor_slug": "neurolens-inc",
"status": "overdue",
"is_pact": false,
"days_late": 813
},
{
"registry_id": "NCT05292755",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05292755",
"title": "Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome: a Randomized, Controlled, Double-Blind Study",
"has_exemption": false,
"start_date": "2022-04-22",
"completion_date": "2022-05-30",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01547741",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01547741",
"title": "A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer",
"has_exemption": false,
"start_date": "2012-04-30",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "NSABP Foundation Inc",
"sponsor_slug": "nsabp-foundation-inc",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02041260",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02041260",
"title": "A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting",
"has_exemption": false,
"start_date": "2014-01-31",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Thomas Jefferson University",
"sponsor_slug": "thomas-jefferson-university",
"status": "overdue",
"is_pact": true,
"days_late": 812
},
{
"registry_id": "NCT02162810",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02162810",
"title": "Effect of Steroids on Post-Operative Complications Following Proximal Hypospadias Repair",
"has_exemption": false,
"start_date": "2014-05-31",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Francis Schneck",
"sponsor_slug": "francis-schneck",
"status": "reported-late",
"is_pact": true,
"days_late": 156
},
{
"registry_id": "NCT02400255",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02400255",
"title": "A Phase II Study of Crenolanib Besylate Maintenance Following Allogeneic Stem Cell Transplantation in Patients With FLT3-positive Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2015-09-30",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Arog Pharmaceuticals, Inc.",
"sponsor_slug": "arog-pharmaceuticals-inc",
"status": "reported-late",
"is_pact": true,
"days_late": 162
},
{
"registry_id": "NCT02643966",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02643966",
"title": "Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT (Also Known as \"DBTUST-Dense Breast Tomosynthesis / Ultrasound Screening Trial\")",
"has_exemption": false,
"start_date": "2015-12-31",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Wendie Berg",
"sponsor_slug": "wendie-berg",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02793583",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02793583",
"title": "A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2016-05-25",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "TG Therapeutics, Inc.",
"sponsor_slug": "tg-therapeutics-inc",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02415309",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02415309",
"title": "Premedication With Melatonin vs. Placebo in Patients Undergoing Interventional Pain Procedure",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "United States Naval Medical Center, San Diego",
"sponsor_slug": "united-states-naval-medical-center-san-diego",
"status": "overdue",
"is_pact": true,
"days_late": 812
},
{
"registry_id": "NCT02657005",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02657005",
"title": "A Phase 1 / 2, Dose Escalation Study of Intravenous TK216 in Patients With Relapsed or Refractory Ewing Sarcoma",
"has_exemption": false,
"start_date": "2016-08-31",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Oncternal Therapeutics, Inc",
"sponsor_slug": "oncternal-therapeutics-inc",
"status": "reported-late",
"is_pact": true,
"days_late": 454
},
{
"registry_id": "NCT02766582",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02766582",
"title": "Phase II Open Label Nonrandomized Trial of the Anti PD 1 Therapy Pembrolizumab With First Line Platinum Based Chemotherapy Followed by 12 Months Pembrolizumab Monotherapy for Patients With Stage III/IV Epithelial Ovarian Cancer",
"has_exemption": false,
"start_date": "2016-10-31",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02880319",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02880319",
"title": "Phase II Protocol Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone",
"has_exemption": false,
"start_date": "2016-11-29",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "reported-late",
"is_pact": true,
"days_late": 26
},
{
"registry_id": "NCT02906332",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02906332",
"title": "A Phase II Trial of the Anti -PD-1 Monoclonal Antibody Pembrolizumab (MK-3475) + Lenalidomide + Dexamethasone as Post Autologous Transplant Consolidation in Patients With High-risk Multiple Myeloma",
"has_exemption": false,
"start_date": "2016-12-12",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "reported-late",
"is_pact": true,
"days_late": 22
},
{
"registry_id": "NCT03040999",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03040999",
"title": "A Randomized Phase III Study of Pembrolizumab Given Concomitantly With Chemoradiation and as Maintenance Therapy Versus Chemoradiation Alone in Subjects With Locally Advanced Head and Neck Squamous Cell Carcinoma (KEYNOTE-412)",
"has_exemption": false,
"start_date": "2017-04-05",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03215914",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03215914",
"title": "Effect of Hybrid Closed-Loop Insulin Delivery on Glucose Counterregulation in Long Standing Type 1 Diabetes: A Proof of Concept, Mechanistic, Single-Arm Clinical Trial",
"has_exemption": false,
"start_date": "2017-08-01",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "reported-late",
"is_pact": false,
"days_late": 92
},
{
"registry_id": "NCT01986205",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01986205",
"title": "A Double-blind Randomized Trial of Hyperbaric Oxygen Versus Sham for Persistent Symptoms After Brain Injury",
"has_exemption": false,
"start_date": "2017-09-06",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Lindell Weaver",
"sponsor_slug": "lindell-weaver",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT03384784",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03384784",
"title": "Targeting the Cholinergic Pathway in HIV-associated Inflammation and Cognitive Dysfunction",
"has_exemption": true,
"start_date": "2017-10-30",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Pennsylvania",
"sponsor_slug": "university-of-pennsylvania",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03359902",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03359902",
"title": "Treatment of Mild Cognitive Impairment With Transcutaneous Vagal Nerve Stimulation",
"has_exemption": false,
"start_date": "2018-01-01",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03746080",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03746080",
"title": "A Follow-Up Study to Add Whole Brain Radiotherapy (WBRT) to Standard Temozolomide Chemo-Radiotherapy in Newly Diagnosed Glioblastoma (GBM) Treated With 4 Weeks of Continuous Infusion Plerixafor",
"has_exemption": false,
"start_date": "2018-12-04",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Lawrence D Recht",
"sponsor_slug": "lawrence-d-recht",
"status": "reported-late",
"is_pact": false,
"days_late": 275
},
{
"registry_id": "NCT03808480",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03808480",
"title": "Nivolumab After Cyclophosphamide and Doxorubicin(CA) Induction Therapy in Previously Treated Advanced Non-squamous Cell Non-small Cell Lung Cancer With PD-L1<10%",
"has_exemption": false,
"start_date": "2019-01-23",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "National Cancer Center, Korea",
"sponsor_slug": "national-cancer-center-korea",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT03818737",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03818737",
"title": "Randomized Multicenter Phase 3 Single-blind Trial Comparing the Efficacy of Corticosteroid Control to Mesenchymal Stem Cell Preparations From Autologous Bone Marrow Concentrate (BMAC), Adipose-derived Stem Cells in the Form of Stromal Vascular Fraction (SVF), and Third-party Human Mesenchymal Stem Cells Manufactured From Umbilical Cord Tissue for the Treatment of Unilateral Knee Osteoarthritis (OA)",
"has_exemption": false,
"start_date": "2019-03-28",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04093141",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04093141",
"title": "Chemotherapy Followed by Irreversible Electroporation in Patients With Unresectable Locally Advanced Pancreatic Cancer (CHEMOFIRE-2)",
"has_exemption": false,
"start_date": "2019-05-01",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery",
"sponsor_slug": "ole-thorlacius-ussing-md-dmsc-professor-of-surgery",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04055623",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04055623",
"title": "Phase 2a Study of the Expansion and Infusion of Autologous T-Regulatory Cells in Amyotrophic Lateral Sclerosis",
"has_exemption": false,
"start_date": "2019-08-07",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT03986203",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03986203",
"title": "Evaluation of the Spry Belt for Improving Bone Quality",
"has_exemption": false,
"start_date": "2019-08-13",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Theranova, L.L.C.",
"sponsor_slug": "theranova-llc",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04057846",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04057846",
"title": "EUS-guided Drainage of Large Walled-off Pancreatic Necrosis Using Lumen Apposing Metal Stents or Standard Double Pigtail Technique. A Single-center, Open-label, Randomized, Superiority Trial",
"has_exemption": false,
"start_date": "2019-08-29",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "John Gasdal Karstensen",
"sponsor_slug": "john-gasdal-karstensen",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT03640312",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03640312",
"title": "A Double Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA)",
"has_exemption": false,
"start_date": "2019-08-30",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04087044",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04087044",
"title": "Computerized Rotational Head Impulse Test-Vertical (crHIT-vertical)",
"has_exemption": false,
"start_date": "2019-09-06",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Neurolign",
"sponsor_slug": "neurolign",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04198233",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04198233",
"title": "Impact of Placement of a Diazepam Suppository Intraoperatively on Early Postoperative Pain Following Pelvic Reconstructive Surgery: a Double-Blind, Randomized Placebo-Controlled Trial",
"has_exemption": false,
"start_date": "2020-02-12",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "TriHealth Inc.",
"sponsor_slug": "trihealth-inc",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04241224",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04241224",
"title": "A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages",
"has_exemption": false,
"start_date": "2020-02-26",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Ra Medical Systems",
"sponsor_slug": "ra-medical-systems",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04248361",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04248361",
"title": "A Randomized, Open-label, Multi-Center, Prospective Study to Assess the Clinical Utility of TEM-PCR™ Upper Respiratory Panel in Adult Patients 65 and Older Presenting With Symptoms of Acute Respiratory Illness",
"has_exemption": false,
"start_date": "2020-03-06",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Diatherix Laboratories, LLC",
"sponsor_slug": "diatherix-laboratories-llc",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04335084",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04335084",
"title": "A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",
"has_exemption": false,
"start_date": "2020-06-22",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "ProgenaBiome",
"sponsor_slug": "progenabiome",
"status": "reported-late",
"is_pact": false,
"days_late": 750
},
{
"registry_id": "NCT04493021",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04493021",
"title": "Evaluation of the Dermal Cooling System for the Enhanced Treatment of Benign Pigmented Lesions and Common Skin Conditions",
"has_exemption": false,
"start_date": "2020-07-07",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "R2 Dermatology",
"sponsor_slug": "r2-dermatology",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04468230",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04468230",
"title": "Phase 2 Study of Nicotine for the Treatment of Pain Associated With Chemotherapy-Induced Peripheral Neuropathy",
"has_exemption": true,
"start_date": "2020-07-31",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04311957",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04311957",
"title": "A Randomized Non-Inferiority Trial to Compare the Efficacy of Switching From Protease-Inhibitor Based Second-Line Therapy to Bictegravir-Tenofovir Alafenamide-Emtricitabine in Virologically Suppressed Adults in Haiti",
"has_exemption": false,
"start_date": "2020-09-01",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic",
"sponsor_slug": "haitian-group-for-the-study-of-kaposis-sarcoma-and-opportunistic",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT03633721",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03633721",
"title": "Acute Effects of Cannabis on Cognition and Mobility in Older HIV-infected and Uninfected Women",
"has_exemption": false,
"start_date": "2020-10-23",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Albert Einstein College of Medicine",
"sponsor_slug": "albert-einstein-college-of-medicine",
"status": "reported-late",
"is_pact": false,
"days_late": 474
},
{
"registry_id": "NCT04780854",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04780854",
"title": "Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)",
"has_exemption": false,
"start_date": "2020-11-03",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Cairo University",
"sponsor_slug": "cairo-university",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04993066",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04993066",
"title": "Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro/ GentleMax Pro Plus",
"has_exemption": false,
"start_date": "2020-11-12",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04429022",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04429022",
"title": "Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy",
"has_exemption": false,
"start_date": "2020-11-24",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "State University of New York at Buffalo",
"sponsor_slug": "state-university-of-new-york-at-buffalo",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04891614",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04891614",
"title": "THE PRISM-PTSD PILOT TRIAL (Process-Instructed Self Neuro-Modulation (\"Prism\") Pilot Trial for Post-Traumatic Stress Disorder)",
"has_exemption": false,
"start_date": "2020-11-29",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "GrayMatters Health Ltd.",
"sponsor_slug": "graymatters-health-ltd",
"status": "reported-late",
"is_pact": false,
"days_late": 699
},
{
"registry_id": "NCT04473690",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04473690",
"title": "A Phase I/II, First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVID-19 SARS-CoV-2 Vaccine With CpG Adjuvant in Healthy Adults Aged 18-49 and 50-85",
"has_exemption": false,
"start_date": "2020-12-30",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "KBio Inc",
"sponsor_slug": "kbio-inc",
"status": "reported-late",
"is_pact": false,
"days_late": 694
},
{
"registry_id": "NCT03360019",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT03360019",
"title": "Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support: Phase II",
"has_exemption": false,
"start_date": "2021-01-27",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05217160",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05217160",
"title": "Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers",
"has_exemption": false,
"start_date": "2021-05-11",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "The Metis Foundation",
"sponsor_slug": "the-metis-foundation",
"status": "reported-late",
"is_pact": false,
"days_late": 505
},
{
"registry_id": "NCT04930705",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04930705",
"title": "Prospective Clinical Study To Assess The Safety And Efficacy Of The Tempsure Flexsure Applicators For The Treatment Of Abdominal Wrinkles",
"has_exemption": false,
"start_date": "2021-05-17",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Cynosure, Inc.",
"sponsor_slug": "cynosure-inc",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04604652",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04604652",
"title": "A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC",
"has_exemption": false,
"start_date": "2021-05-27",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "HighTide Biopharma Pty Ltd",
"sponsor_slug": "hightide-biopharma-pty-ltd",
"status": "reported-late",
"is_pact": false,
"days_late": 99
},
{
"registry_id": "NCT05157763",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05157763",
"title": "An Open-Label Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-06-30",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "MediWound Ltd",
"sponsor_slug": "mediwound-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT05222503",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05222503",
"title": "The Impact of Sensor Technology in Individuals With Knee OA",
"has_exemption": false,
"start_date": "2021-08-19",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "OPUM Technologies US LTD",
"sponsor_slug": "opum-technologies-us-ltd",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT05009524",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05009524",
"title": "The Interactive Physical and Cognitive Exercise System (iPACES v3) to Benefit Brain Health in Mild Cognitive Impairment (MCI): A Randomized Clinical Trial of Neuro-exergaming Pedal-to-play (iPACES) vs Pedal-while-play (PACE)",
"has_exemption": false,
"start_date": "2021-08-23",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "iPACES LLC",
"sponsor_slug": "ipaces-llc",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT05066724",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05066724",
"title": "Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment",
"has_exemption": true,
"start_date": "2021-09-15",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04732624",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04732624",
"title": "Implementation of an Enteral Resuscitation Bundle for Moderate-sized Burn Injuries (20-40% Total Body Surface Area) to Prevent Shock, Coagulopathy, and Kidney and Lung Injury in Nepal",
"has_exemption": false,
"start_date": "2021-09-30",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "reported-late",
"is_pact": false,
"days_late": 53
},
{
"registry_id": "NCT05186298",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05186298",
"title": "Prospective Evaluation and Comparison of Bilateral Synergy Implants and Bilateral PanOptix Implants",
"has_exemption": false,
"start_date": "2021-11-02",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Alterman, Modi, & Wolter Ophthalmic Physicians & Surgeons",
"sponsor_slug": "alterman-modi-wolter-ophthalmic-physicians-surgeons",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT05013385",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05013385",
"title": "Multi-center, Double-blind, Randomized, Placebo-controlled, Phase IIa Trial to Evaluate Spesolimab (BI 655130) Efficacy in Patients With Fibrostenotic Crohn's Disease",
"has_exemption": false,
"start_date": "2021-11-09",
"completion_date": "2022-05-31",
"has_results": true,
"results_due": true,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "reported",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05087563",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05087563",
"title": "Randomized Controlled Double Masked Two Arm Cross-over Study of Neurolenses in Subjects With Convergence Insufficiency",
"has_exemption": false,
"start_date": "2021-11-22",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Neurolens Inc.",
"sponsor_slug": "neurolens-inc",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT04875104",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT04875104",
"title": "A Randomized Clinical Trial on Upper Sequential Distalization With Temporary Anchorage Devices (TADs) and Two Aligner Systems",
"has_exemption": false,
"start_date": "2021-11-30",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Universidad Complutense de Madrid",
"sponsor_slug": "universidad-complutense-de-madrid",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT05096065",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT05096065",
"title": "An Open-label Dose-finding Study to Evaluate the Pharmacodynamic (PD) Profiles and Efficacy of Different Dosing Regimens of Leuprolide Oral Tablets (Ovarest®) in Women With Endometriosis",
"has_exemption": false,
"start_date": "2022-03-18",
"completion_date": "2022-05-31",
"has_results": false,
"results_due": true,
"sponsor_name": "Enteris BioPharma Inc.",
"sponsor_slug": "enteris-biopharma-inc",
"status": "overdue",
"is_pact": false,
"days_late": 812
},
{
"registry_id": "NCT01662466",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT01662466",
"title": "A Randomized Double Blind Control Trial of Transdermal Testosterone Supplementation vs Placebo on Follicular Development and Atresia, Oocyte and Embryo Quality Among Women With Diminished Ovarian Reserve Undergoing in Vitro Fertilization",
"has_exemption": false,
"start_date": "2012-07-01",
"completion_date": "2022-06-01",
"has_results": false,
"results_due": true,
"sponsor_name": "Center for Human Reproduction",
"sponsor_slug": "center-for-human-reproduction",
"status": "overdue",
"is_pact": true,
"days_late": 811
},
{
"registry_id": "NCT02369458",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02369458",
"title": "Phase II Trial of Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies",
"has_exemption": false,
"start_date": "2015-04-14",
"completion_date": "2022-06-01",
"has_results": true,
"results_due": true,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "reported",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02143414",
"publication_url": "https://clinicaltrials.gov/ct2/show/NCT02143414",
"title": "A Phase 2 Study of Blinatumomab and POMP (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) for Patients >/= 65 Years of Age With Newly Diagnosed Philadelphia-Chromosome Negative (Ph-) Acute Lymphoblastic Leukemia (ALL) and of Dasatinib, Prednisone and Blinatumomab for Patients >/= 65 Years of Age With Newly Diagnosed Philadelphia-Chromosome Positive (Ph+) ALL, Relapsed/Refractory Ph+ ALL, and Philadelphia-Chromosome-Like Signature (Ph-Like) ALL (Newly Diagnosed or Relapsed/Refractory) With Known or Presumed Activating Dasatinib-Sensitive Mutations or Kinase Fusions (DSMKF)",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2022-06-01",
"has_results": true,
"results_due": true,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "reported",
"is_pact": true,
"days_late": null
}
]
}